Growth Metrics

Omeros (OMER) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.00%
Dec 31, 2025 102.45%
Sep 30, 2025 -25.57%
Jun 30, 2025 11.00%
Mar 31, 2025 -57.30%
Dec 31, 2024 -8.14%
Sep 30, 2024 55.44%
Jun 30, 2024 -36.08%
Mar 31, 2024 -1.23%
Dec 31, 2023 -16.82%
Sep 30, 2023 16.74%
Jun 30, 2023 -6.16%
Mar 31, 2023 -9.53%
Dec 31, 2022 -15.09%
Sep 30, 2022 25.13%
Jun 30, 2022 -21.07%
Mar 31, 2022 -29.85%
Dec 31, 2021 -2.56%
Sep 30, 2021 82.68%
Jun 30, 2021 -4.71%
Mar 31, 2021 -13.99%
Dec 31, 2020 -0.55%
Sep 30, 2020 0.05%
Jun 30, 2020 9.95%
Mar 31, 2020 4.79%
Dec 31, 2019 -5.12%
Sep 30, 2019 -2.83%
Jun 30, 2019 6.64%
Mar 31, 2019 19.77%
Dec 31, 2018 -3.82%
Sep 30, 2018 -2.37%
Jun 30, 2018 1.15%
Mar 31, 2018 -8.43%
Dec 31, 2017 6.51%
Sep 30, 2017 -2.91%
Jun 30, 2017 -4.40%
Mar 31, 2017 -18.43%
Dec 31, 2016 58.42%
Sep 30, 2016 -2.87%
Jun 30, 2016 -40.98%
Mar 31, 2016 91.59%
Dec 31, 2015 -2.86%
Sep 30, 2015 -0.17%
Jun 30, 2015 -5.44%
Mar 31, 2015 -34.37%
Dec 31, 2014 130.33%
Sep 30, 2014 2.15%
Jun 30, 2014 -8.84%
Mar 31, 2014 -5.30%
Dec 31, 2013 -14.61%
Sep 30, 2013 108.58%
Jun 30, 2013 -3.02%
Mar 31, 2013 -45.49%
Dec 31, 2012 248.09%
Sep 30, 2012 1.23%
Jun 30, 2012 -49.69%
Mar 31, 2012 148.57%
Dec 31, 2011 -2.57%
Sep 30, 2011 -14.63%
Jun 30, 2011 19.43%
Mar 31, 2011 -24.17%
Dec 31, 2010 5.23%